138 related articles for article (PubMed ID: 33310031)
1. WY14643 improves left ventricular myocardial mitochondrial and systolic functions in obese rats under chronic persistent hypoxia via the PPARα pathway.
Yan J; Song K; Bai Z; Ge RL
Life Sci; 2021 Feb; 266():118888. PubMed ID: 33310031
[TBL] [Abstract][Full Text] [Related]
2. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of PPARα normalizes the skin lipid ratio and improves the skin barrier of normal and filaggrin deficient reconstructed skin.
Wallmeyer L; Lehnen D; Eger N; Sochorová M; Opálka L; Kováčik A; Vávrová K; Hedtrich S
J Dermatol Sci; 2015 Nov; 80(2):102-10. PubMed ID: 26472199
[TBL] [Abstract][Full Text] [Related]
4. The effects of a PPARalpha agonist on myocardial damage in obese diabetic mice with heart failure.
Chen R; Liang F; Morimoto S; Li Q; Moriya J; Yamakawa J; Takahashi T; Iwai K; Kanda T
Int Heart J; 2010 May; 51(3):199-206. PubMed ID: 20558911
[TBL] [Abstract][Full Text] [Related]
5. Long-Term High-Fat Diet Inhibits the Recovery of Myocardial Mitochondrial Function After Chronic Hypoxia Reoxygenation in Rats.
Yan J; Song K; Zhou S; Ge RL
High Alt Med Biol; 2021 Sep; 22(3):327-334. PubMed ID: 34191588
[TBL] [Abstract][Full Text] [Related]
6. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure.
Morgan EE; Rennison JH; Young ME; McElfresh TA; Kung TA; Tserng KY; Hoit BD; Stanley WC; Chandler MP
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1899-904. PubMed ID: 16339830
[TBL] [Abstract][Full Text] [Related]
8. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling.
Song K; Zhang Y; Ga Q; Bai Z; Ge RL
Life Sci; 2020 Jul; 252():117633. PubMed ID: 32289432
[TBL] [Abstract][Full Text] [Related]
9. Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: Reduction of PPARα.
Bian X; Su X; Wang Y; Zhao G; Zhang B; Li D
Biochimie; 2019 May; 160():172-182. PubMed ID: 30890453
[TBL] [Abstract][Full Text] [Related]
10. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
[TBL] [Abstract][Full Text] [Related]
12. Dual PPARα/γ ligand TZD18 improves myocardial metabolic remodeling after myocardial infarction in rats.
Chen XL; Liu ZR; Xue YJ; Chen X
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5765-5773. PubMed ID: 29272013
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats.
Tanajak P; Sa-Nguanmoo P; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
Acta Physiol (Oxf); 2016 Aug; 217(4):287-99. PubMed ID: 27119620
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
[No Abstract] [Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
Baranowski M; Blachnio-Zabielska A; Gorski J
J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.
Patsouris D; Reddy JK; Müller M; Kersten S
Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
Bernardes A; Souza PC; Muniz JR; Ricci CG; Ayers SD; Parekh NM; Godoy AS; Trivella DB; Reinach P; Webb P; Skaf MS; Polikarpov I
J Mol Biol; 2013 Aug; 425(16):2878-93. PubMed ID: 23707408
[TBL] [Abstract][Full Text] [Related]
19. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
[TBL] [Abstract][Full Text] [Related]
20. PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms.
Reichenbach G; Starzinski-Powitz A; Sloane BF; Doll M; Kippenberger S; Bernd A; Kaufmann R; Meissner M
Angiogenesis; 2013 Jan; 16(1):223-33. PubMed ID: 23096928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
